Dimensional Fund Advisors LP Biomarin Pharmaceutical Inc Transaction History

Dimensional Fund Advisors LP

$376 Billion
Q2 2024

A detailed history of Dimensional Fund Advisors LP transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 1,034,457 shares of BMRN stock, worth $73 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,034,457

Previous 744,504 38.95%

Holding current value

$73 Million

Previous $65 Million 30.98%

% of portfolio

0.02%

Previous 0.02%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$74.43 - $92.22 $21.6 Million - $26.7 Million	289,953 Added 38.95%	1,034,457 $85.2 Million
Q1 2024 May 10, 2024	BUY	$83.81 - $99.0 $3.31 Million - $3.92 Million	39,551 Added 5.61%	744,504 $65 Million
Q4 2023 Feb 07, 2024	BUY	$76.22 - $98.51 $5.48 Million - $7.08 Million	71,853 Added 11.35%	704,953 $68 Million
Q3 2023 Nov 09, 2023	SELL	$85.07 - $94.48 $1.24 Million - $1.38 Million	-14,603 Reduced 2.25%	633,100 $56 Million
Q2 2023 Aug 09, 2023	BUY	$86.68 - $100.3 $2.91 Million - $3.37 Million	33,581 Added 5.47%	647,703 $56.1 Million
Q1 2023 May 12, 2023	BUY	$87.74 - $117.27 $3.13 Million - $4.18 Million	35,630 Added 6.16%	614,122 $59.7 Million
Q4 2022 Feb 09, 2023	BUY	$80.93 - $108.63 $854,458 - $1.15 Million	10,558 Added 1.86%	578,492 $59.9 Million
Q3 2022 Nov 10, 2022	BUY	$82.16 - $96.94 $605,519 - $714,447	7,370 Added 1.31%	567,934 $48.1 Million
Q2 2022 Aug 12, 2022	BUY	$71.48 - $86.85 $459,902 - $558,792	6,434 Added 1.16%	560,564 $46.5 Million
Q1 2022 May 13, 2022	BUY	$74.28 - $92.69 $156,582 - $195,390	2,108 Added 0.38%	554,130 $42.7 Million
Q4 2021 Feb 09, 2022	BUY	$71.72 - $91.47 $1.92 Million - $2.45 Million	26,813 Added 5.11%	552,022 $48.8 Million
Q3 2021 Nov 12, 2021	BUY	$74.77 - $85.47 $3.85 Million - $4.41 Million	51,547 Added 10.88%	525,209 $40.6 Million
Q2 2021 Aug 12, 2021	BUY	$75.51 - $84.79 $2.14 Million - $2.41 Million	28,376 Added 6.37%	473,662 $39.5 Million
Q1 2021 May 14, 2021	BUY	$74.73 - $90.69 $1.27 Million - $1.54 Million	16,990 Added 3.97%	445,286 $33.6 Million
Q4 2020 Feb 25, 2021	BUY	$72.61 - $90.2 $31.1 Million - $38.6 Million	428,296 New	428,296 $37.6 Million

Others Institutions Holding BMRN

# of Institutions

632

Shares Held

185M

Call Options Held

1.63M

Put Options Held

1.2M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Biomarin Pharmaceutical Inc Transaction History